- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07419685
Intraoral Appliance (IOA) Model Evaluating the Efficacy of a Whitening Toothpaste
February 12, 2026 updated by: Church & Dwight Company, Inc.
Intraoral Appliance (IOA) Model Evaluating the Efficacy of Three Dentifrices on Enamel Lesion Remineralization
This single-center, randomized, double-blind, three-period crossover in situ study evaluated the enamel remineralization potential and fluoride bioavailability of three dentifrices-one fluoride-free negative control, one positive control with 0.243% sodium fluoride, and one investigational dentifrice containing 0.243% sodium fluoride and 20% sodium bicarbonate.
Healthy adult subjects wore a palatal acrylic appliance containing demineralized enamel specimens for three 9-day treatment periods, during which in vivo brushing/slurry exposure and ex vivo sucrose challenges were performed.
Outcomes included percent surface microhardness recovery (%SMHR) and post-treatment enamel fluoride concentration.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This in situ intraoral appliance (IOA) model evaluates anticaries potential by exposing demineralized enamel specimens to oral conditions while allowing for ex vivo treatment assessments.
Subjects wore acrylic palatal appliances containing four enamel specimens covered with steel gauze to promote plaque formation.
Each of the three treatment periods lasted nine days and included twice-daily toothbrushing and dentifrice slurry swishing, plus three daily sucrose challenges.
A minimum 4-day fluoride-free washout preceded each period.
Post-treatment specimens were analyzed for %SMHR and enamel fluoride concentration.
Study Type
Interventional
Enrollment (Actual)
31
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Indiana
-
Noblesville, Indiana, United States, 46060
- Therametric Technologies, Inc.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Adults ≥18 years
- Good general and oral health
- Normal unstimulated salivary flow (≥1.5 mL/5 min)
- Functional dentition
- Oral conditions adequate to support the palatal appliance
- Ability to comply with brushing, slurry, appliance wear, and sucrose challenge procedures
Exclusion Criteria:
- Inability to tolerate appliance
- Oral pathology that interferes with participation
- Antibiotic use that violates withdrawal criteria
- Use of fluoride toothpaste during washout
- Participation in another appliance study in the past 4 weeks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Comparator
|
Commercially available fluoride toothpaste
|
|
Placebo Comparator: Negative Control Toothpaste
Fluoride-free dentifrice (0 ppm fluoride).
Used for twice-daily brushing and slurry swishing during each test day.
|
Fluoride-free toothpaste
|
|
Experimental: Test Toothpaste
|
lnvestigational fluoride toothpaste
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Percent Surface Microhardness Recovery (%SMHR) [Time Frame: End of each 9-day test period (three test periods in total)]
Time Frame: End of each 9#day test period (three test periods in total)
|
End of each 9#day test period (three test periods in total)
|
|
Post-treatment fluoride concentration (µg F/g enamel)
Time Frame: End of each 9-day test period (three test periods in total
|
End of each 9-day test period (three test periods in total
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Annahita Ghassemi, PhD, Church & Dwight, Inc.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 8, 2024
Primary Completion (Actual)
January 17, 2025
Study Completion (Actual)
January 17, 2025
Study Registration Dates
First Submitted
February 12, 2026
First Submitted That Met QC Criteria
February 12, 2026
First Posted (Actual)
February 19, 2026
Study Record Updates
Last Update Posted (Actual)
February 19, 2026
Last Update Submitted That Met QC Criteria
February 12, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ST-24-U44
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The sponsor does not plan to share individual participant data (IPD) from this study.
Summary results will be provided as required, but no de-identified datasets or additional supporting documents will be made available.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Caries
-
National University of San Marcos, PeruNot yet recruitingPit and Fissure Caries | Caries,Dental | Sealant DentalPeru
-
Ain Shams UniversityCompletedPulpitis | Caries | Caries,Dental | Reversible Pulpitis | Caries Class I | Caries; DentinEgypt
-
University of MinnesotaCompletedUsing Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood CariesCaries | Caries,DentalUnited States
-
Future University in EgyptNot yet recruitingDeep Caries | Caries, Dental
-
Federal University of PelotasRecruiting
-
Kompetansesenteret Tannhelse Midt (TkMidt)Karolinska Institutet; University of Bergen; Norwegian University of Science... and other collaboratorsActive, not recruiting
-
Marmara UniversityCompleted
-
Suez Canal UniversityCompleted
-
Pomeranian Medical University SzczecinCompleted
-
Rawda Hesham Abd ElAzizRecruitingCaries,Dental | Caries Class IIEgypt
Clinical Trials on Negative Control Toothpaste
-
Church & Dwight Company, Inc.CompletedDental CariesUnited States
-
GlaxoSmithKlineCompletedHypersensitivity | Dentinal SensitivityUnited States
-
Ministry of Health, Saudi ArabiaUnknown
-
PfizerCompleted
-
GlaxoSmithKlineCompletedDental PlaqueUnited Kingdom
-
Church & Dwight Company, Inc.CompletedGingivitis | PlaqueCanada
-
Unilever R&DRecruitingDental Plaque | Gingival Inflammation | Gingival BleedingIndonesia
-
Church & Dwight Company, Inc.TherametricsCompleted
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Colgate PalmoliveCompletedDentin HypersensitivityChina